Literature DB >> 8981580

Teratogenic actions of ethanol in the mouse: a minireview.

H C Becker1, J L Diaz-Granados, C L Randall.   

Abstract

The deleterious effects of prenatal ethanol exposure have been extensively documented in clinical and experimental studies. This paper provides an overview of work conducted with mice to examine the myriad of adverse consequences that result from embryonic/fetal exposure to ethanol. All of the hallmark features of the clinical fetal alcohol syndrome have been demonstrated in mice, including prenatal and postnatal growth retardation, structural malformations and behavioral abnormalities associated with central nervous system dysfunction. As expected, the severity and profile of effects is related to both dosage level and timing of exposure. In addition, these effects have been demonstrated following acute and chronic exposure, with a variety of routes of administration employed. Furthermore, a number of strains have been used in these studies and the variant response (susceptibility) to the teratogenic actions of ethanol exhibited among different mouse strains support the notion that genetic factors govern, at least in part, vulnerability to these effects of ethanol. More recent studies using mouse models have focused on examining potential mechanisms underlying the full spectrum of ethanol's teratogenic actions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981580     DOI: 10.1016/s0091-3057(96)00255-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  34 in total

1.  Exposure to alcohol-containing medications during pregnancy.

Authors:  Facundo Garcia-Bournissen; Yaron Finkelstein; Massoud Rezvani; Gideon Koren
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

2.  Low and moderate prenatal ethanol exposures of mice during gastrulation or neurulation delays neurobehavioral development.

Authors:  Uta B Schambra; Jeff Goldsmith; Kevin Nunley; Yali Liu; Sam Harirforoosh; Heidi M Schambra
Journal:  Neurotoxicol Teratol       Date:  2015-07-11       Impact factor: 3.763

Review 3.  Animal models of gene-alcohol interactions.

Authors:  Charles Benjamin Lovely
Journal:  Birth Defects Res       Date:  2019-11-27       Impact factor: 2.344

Review 4.  Gene-environment interactions in development and disease.

Authors:  C Lovely; Mindy Rampersad; Yohaan Fernandes; Johann Eberhart
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-09-14       Impact factor: 5.814

5.  Long-term behavioral changes in response to early developmental exposure to ethanol in zebrafish.

Authors:  Yohaan Fernandes; Robert Gerlai
Journal:  Alcohol Clin Exp Res       Date:  2009-01-12       Impact factor: 3.455

6.  Genetic and epigenetic insights into fetal alcohol spectrum disorders.

Authors:  Michèle Ramsay
Journal:  Genome Med       Date:  2010-04-28       Impact factor: 11.117

7.  Alcohol-induced epigenetic alterations to developmentally crucial genes regulating neural stemness and differentiation.

Authors:  Kylee J Veazey; Mindy N Carnahan; Daria Muller; Rajesh C Miranda; Michael C Golding
Journal:  Alcohol Clin Exp Res       Date:  2013-03-12       Impact factor: 3.455

Review 8.  Effects of prenatal alcohol exposure (PAE): insights into FASD using mouse models of PAE.

Authors:  Berardino Petrelli; Joanne Weinberg; Geoffrey G Hicks
Journal:  Biochem Cell Biol       Date:  2018-01-25       Impact factor: 3.626

9.  Identification of cell-specific patterns of reference gene stability in quantitative reverse-transcriptase polymerase chain reaction studies of embryonic, placental and neural stem models of prenatal ethanol exposure.

Authors:  Mindy N Carnahan; Kylee J Veazey; Daria Muller; Joseph D Tingling; Rajesh C Miranda; Michael C Golding
Journal:  Alcohol       Date:  2013-01-11       Impact factor: 2.405

10.  A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth.

Authors:  Feng C Zhou; Youssef Sari; Teresa A Powrozek; Catherine Y Spong
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.